Literature DB >> 19122982

[Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Hildegard Pape1, Klaus Orth, Rainer Engers, Christiane Matuschek, Anja Müller, Karl-Axel Hartmann, Peter Arne Gerber, Guido Lammering, Daniel Habermehl, Roland Fenk, Wilfried Budach, Stephan Gripp, Matthias Peiper, Edwin Bölke.   

Abstract

The management of soft tissue sarcoma has evolved from a solitary surgical treatment to an interdisciplinary multimodal approach including radiotherapy. These fundamental changes are the result of increased knowledge in tumor biology, radiation sensitivity and the improvement in modern radiation therapy techniques. A successful effective therapy regimen strongly depends on distinct preoperative diagnostics, preoperative conception of the surgical intervention and an experienced oncological team. Of significant importance for the prognosis is early diagnosis as well as tumor excision with a wide negative margin. However, even after complete wide resection in sano, the use of postoperative radiotherapy can further improve local control and should therefore be applied to the majority of patients. Consequently, radiotherapy should only be omitted in cases in which the tumor has been excised with a very wide negative margin; this implies, however, high quality of surgery and distinct histopathological analysis. Patients with non- or questionable resectable tumors, should be referred for pre-operative radiotherapy in order to improve the surgical results. Recent studies have underlined the efficiency of modern radiotherapy regimens. The different radiotherapy regimens will be highlighted against the background of tumor stage and tumor resectibility.

Entities:  

Mesh:

Year:  2008        PMID: 19122982     DOI: 10.1007/s00508-008-1115-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  52 in total

1.  Local recurrence in soft tissue sarcoma: more about the tumor, less about the surgeon.

Authors:  Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2007-02-13       Impact factor: 5.344

2.  Local control and survival in soft tissue sarcomas of the limbs, trunk walls and head and neck: a study of 113 cases.

Authors:  J S Abbatucci; N Boulier; J de Ranieri; A M Mandard; A Tanguy; J C Vernhes; J C Lozier; A Busson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

3.  The problem of local recurrence after treatment of soft tissue sarcoma.

Authors:  J Cantin; G P McNeer; F C Chu; R J Booher
Journal:  Ann Surg       Date:  1968-07       Impact factor: 12.969

4.  Sarcoma of soft tissues: radiation sensitivity, treatment field margins, pathological margins, and dose--on Fein et al., IJROBP 32:969-976; 1995.

Authors:  H Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038

5.  Postoperative radiotherapy in the treatment of extremity soft tissue sarcomas.

Authors:  W J Pao; M V Pilepich
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-10       Impact factor: 7.038

6.  The histologic response of soft tissue sarcoma to radiation therapy.

Authors:  C G Willett; A L Schiller; H D Suit; H J Mankin; A Rosenberg
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

7.  Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy.

Authors:  A N Wilson; A Davis; R S Bell; B O'Sullivan; C Catton; F Madadi; R Kandel; V L Fornasier
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

8.  Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control?

Authors:  D A Fein; W R Lee; R M Lanciano; B W Corn; S H Herbert; A L Hanlon; J P Hoffman; B L Eisenberg; L R Coia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-15       Impact factor: 7.038

9.  The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Authors:  Walter Rhomberg
Journal:  Sarcoma       Date:  2006

10.  Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation.

Authors:  Robert J van Ginkel; Katja M J Thijssens; Elisabeth Pras; Winette T A van der Graaf; Albert J H Suurmeijer; Harald J Hoekstra
Journal:  Ann Surg Oncol       Date:  2007-01-26       Impact factor: 5.344

View more
  1 in total

1.  Malignant tumours of the hand and wrist.

Authors:  Binu P Thomas; Kiran Sasi; Samuel Cr Pallapati; Anil Mathew; R Sreekanth; Meera Thomas
Journal:  Indian J Plast Surg       Date:  2011-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.